Efficacy of low‐dose colchicine on left ventricular hypertrophy in patients with coronary artery disease: A randomized controlled trial

Key Result

Low-dose colchicine significantly reduced left ventricular hypertrophy in patients with coronary artery disease compared to the placebo group.

Key Points

• The aim is to evaluate the impact of low-dose colchicine on left ventricular hypertrophy in patients with coronary artery disease.
• Conducted a randomized controlled trial
• Enrolled patients with coronary artery disease
• Administered low-dose colchicine as intervention
• Assessed left ventricular hypertrophy as the outcome measure
• Colchicine treatment shows a reduction in left ventricular hypertrophy
• Significant improvement in cardiac function metrics
• No adverse effects reported during the study